503 related articles for article (PubMed ID: 15272408)
1. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus.
Quinlivan ML; Gershon AA; Steinberg SP; Breuer J
J Infect Dis; 2004 Aug; 190(4):793-6. PubMed ID: 15272408
[TBL] [Abstract][Full Text] [Related]
2. Herpes zoster with skin lesions and meningitis caused by 2 different genotypes of the Oka varicella-zoster virus vaccine.
Levin MJ; DeBiasi RL; Bostik V; Schmid DS
J Infect Dis; 2008 Nov; 198(10):1444-7. PubMed ID: 18826373
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of single nucleotide polymorphisms used to differentiate vaccine and wild type strains of varicella-zoster virus.
Quinlivan M; Gershon AA; Steinberg SP; Breuer J
J Med Virol; 2005 Jan; 75(1):174-80. PubMed ID: 15543576
[TBL] [Abstract][Full Text] [Related]
4. Vaccine Oka varicella-zoster virus genotypes are monomorphic in single vesicles and polymorphic in respiratory tract secretions.
Quinlivan MA; Gershon AA; Nichols RA; La Russa P; Steinberg SP; Breuer J
J Infect Dis; 2006 Apr; 193(7):927-30. PubMed ID: 16518753
[TBL] [Abstract][Full Text] [Related]
5. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany.
Sauerbrei A; Wutzler P
J Med Virol; 2007 Jul; 79(7):1025-31. PubMed ID: 17516537
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain.
Sauerbrei A; Eichhorn U; Gawellek S; Egerer R; Schacke M; Wutzler P
J Med Virol; 2003 Oct; 71(2):313-9. PubMed ID: 12938208
[TBL] [Abstract][Full Text] [Related]
7. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine.
Loparev VN; Rubtcova E; Seward JF; Levin MJ; Schmid DS
J Infect Dis; 2007 Feb; 195(4):502-10. PubMed ID: 17230409
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of clinical varicella-zoster strains from India and differentiation from the oka vaccine strain.
Kaushik KS; Lahiri KK; Chumber SK; Gupta RM; Kumar S; Kapila K; Karade S
Jpn J Infect Dis; 2008 Jan; 61(1):65-7. PubMed ID: 18219137
[TBL] [Abstract][Full Text] [Related]
9. The safety profile of varicella vaccine: a 10-year review.
Galea SA; Sweet A; Beninger P; Steinberg SP; Larussa PS; Gershon AA; Sharrar RG
J Infect Dis; 2008 Mar; 197 Suppl 2():S165-9. PubMed ID: 18419392
[TBL] [Abstract][Full Text] [Related]
10. Vaccine Oka variants and sequence variability in vaccine-related skin lesions.
Breuer J; Schmid DS
J Infect Dis; 2008 Mar; 197 Suppl 2():S54-7. PubMed ID: 18419409
[TBL] [Abstract][Full Text] [Related]
11. [Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus].
Christensen CL; Poulsen A; Böttiger B; Kirk M; Andersen HK; Schmiegelow K
Ugeskr Laeger; 1999 Feb; 161(6):794-6. PubMed ID: 10068350
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster by reactivated vaccine varicella zoster virus in a healthy child.
Uebe B; Sauerbrei A; Burdach S; Horneff G
Eur J Pediatr; 2002 Aug; 161(8):442-4. PubMed ID: 12172829
[TBL] [Abstract][Full Text] [Related]
13. Genetic profile of an Oka varicella vaccine virus variant isolated from an infant with zoster.
Sauerbrei A; Rubtcova E; Wutzler P; Schmid DS; Loparev VN
J Clin Microbiol; 2004 Dec; 42(12):5604-8. PubMed ID: 15583288
[TBL] [Abstract][Full Text] [Related]
14. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine.
Gomi Y; Ozaki T; Nishimura N; Narita A; Suzuki M; Ahn J; Watanabe N; Koyama N; Ushida H; Yasuda N; Nakane K; Funahashi K; Fuke I; Takamizawa A; Ishikawa T; Yamanishi K; Takahashi M
Vaccine; 2008 Oct; 26(44):5627-32. PubMed ID: 18706951
[TBL] [Abstract][Full Text] [Related]
15. Vaccine-strain varicella zoster virus causing recurrent herpes zoster in an immunocompetent 2-year-old.
Ota K; Kim V; Lavi S; Ford-Jones EL; Tipples G; Scolnik D; Tellier R
Pediatr Infect Dis J; 2008 Sep; 27(9):847-8. PubMed ID: 18664930
[TBL] [Abstract][Full Text] [Related]
16. Rapid molecular discrimination between infection with wild-type varicella-zoster virus and varicella vaccine virus.
Lässker U; Harder TC; Hufnagel M; Suttorp M
Infection; 2002 Oct; 30(5):320-2. PubMed ID: 12382096
[TBL] [Abstract][Full Text] [Related]
17. Herpes zoster in childhood.
Leung AK; Robson WL; Leong AG
J Pediatr Health Care; 2006; 20(5):300-3. PubMed ID: 16962434
[TBL] [Abstract][Full Text] [Related]
18. Varicella-zoster-virus genotypes in East London: a prospective study in patients with herpes zoster.
Sengupta N; Taha Y; Scott FT; Leedham-Green ME; Quinlivan M; Breuer J
J Infect Dis; 2007 Oct; 196(7):1014-20. PubMed ID: 17763323
[TBL] [Abstract][Full Text] [Related]
19. Development of varicella vaccine.
Takahashi M; Asano Y; Kamiya H; Baba K; Ozaki T; Otsuka T; Yamanishi K
J Infect Dis; 2008 Mar; 197 Suppl 2():S41-4. PubMed ID: 18419406
[TBL] [Abstract][Full Text] [Related]
20. Analysis of repeat units in the R2 region among different Oka varicella-zoster virus vaccine strains and wild-type strains in Germany.
Sauerbrei A; Zell R; Wutzler P
Intervirology; 2007; 50(1):40-4. PubMed ID: 17164556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]